Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

nhs_england_and_nice_logos

NHS England and NICE announce plans for new Cancer Drugs Fund

November 19, 2015 Medical Communications, Research and Development Cancer Drugs Fund, NHS England, NICE

A 12-week consultation on draft proposals for a revamped Cancer Drugs Fund (CDF) has been launched by NHS England and NICE, …
News
bayer_cross_2

NICE decision restricts Bayer’s Xofigo to select prostate cancer patients

November 19, 2015 Research and Development, Sales and Marketing Bayer, NICE, prostate cancer

NICE has issued its Final Appraisal Determination (FAD) recommending Bayer’s Xofigo (radium-223 dichloride) for use on the NHS in England …
News
nice

Merck criticises NICE ‘no’ to personalised bowel cancer drugs

November 19, 2015 Research and Development

NICE has issued preliminary not recommending two specific personalised treatments used in combination with chemotherapy for previously untreated metastatic colorectal …
News

NICE rejects Amgen’s Repatha in draft guidance

November 18, 2015 Research and Development, Sales and Marketing Amgen, NICE, Repatha, evolocumab, high cholesterol

NICE has published draft guidance rejecting Amgen’s Repatha as a treatment for people with high cholesterol.   
News
Takeda oncology

Challenges in oncology R&D

November 18, 2015 Manufacturing and Production, Research and Development Dixie-Lee Esseltine, Takeda, Takeda oncology, Velcade, multiple myeloma, oncology

Pharmafile put questions on the challenges pharma companies face when working in oncology R&D to Dixie-Lee Esseltine, vice president of …
Feature
FDA sign

FDA accepts regulatory submission for Novartis biosimilar

November 18, 2015 Research and Development, Sales and Marketing Neulasta, Novartis, Sandoz, biosimilar, pegfilgrastim

Novartis’ generics unit Sandoz has announced it has had its Biologics License Application (BLA) for a proposed biosimilar to Amgen’s …
News
pills

Global drug spending will rise 30% by 2020, to $1.4 trillion

November 18, 2015 Research and Development IMS Health, OTC, drug spending, emerging markets, generics, prescribing

Global spending on drugs will increase 30% to $1.4 trillion by 2020, as more patients get access to treatments and …
News
Researcher

Scientists make possible pancreatic cancer discovery

November 18, 2015 Research and Development Pancreatic cancer

Cancer researchers say they have discovered a potential new method of treatment for pancreatic cancer that could improve survival rates.  …
News
steve_turley_linkedin

UCB appoints Steve Turley as MD for Britain and Ireland

November 18, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB

Steve Turley has joined UCB as the company’s managing director for the British and Irish isles, moving from Lundbeck. He …
Appointment
Norgine logo

Norgine opens new £4.5 million warehouse

November 17, 2015 Manufacturing and Production, Research and Development Norgine, Temperature control, Wales, manufacturing, production, temperature-control

Norgine has opened a new £4.5 million temperature controlled warehouse on its current site in Hengoed, Wales.  The Dutch-based firm …
News
dr_kevin_johnson_-_chairman

Crescendo Biologics appoints Dr Kevin Johnson as chairman

November 17, 2015 Research and Development

Crescendo Biologics, the drug discovery and developer of Humabody VH therapeutics, has announced the appointment of Dr Kevin Johnson as non-executive …
Appointment
abbvie_0

AbbVie rules out joining the biosimilars bandwagon

November 17, 2015 Manufacturing and Production, Research and Development

AbbVie says it has ruled out moving into the biosimilars market to stave off competition once its blockbuster drug Humira …
News
genmab

FDA approves ‘first of its kind’ blood cancer drug

November 17, 2015 Manufacturing and Production, Research and Development

The FDA has approved Genmab’s drug Darzalex for patients with multiple myeloma. Darzalex (daratumumab) is the first human CD38 monoclonal antibody …
News
Diabetes treatments

Featured Market Report: Type 2 Diabetes – Epidemiology Forecast to 2024

November 16, 2015 Manufacturing and Production, Research and Development diabetes, market reports

Diabetes is one of the most common non-communicable diseases worldwide and is an escalating public health problem globally, with an …
Feature
baxalta_logo

FDA approves Baxalta Haemophilia A treatment

November 16, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

The US FDA has approved Baxalta’s twice-weekly therapy Adynovate for use in adults and adolescents, aged 12 years plus, with …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026